Immunome, Inc. (IMNM) Total liabilities 2023–2025
Immunome, Inc. (IMNM) total liabilities at each fiscal year-end, per SEC filings.
$48.8MFY2025 · since FY2023: $28.7M → $48.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $48.8M | -17.3% |
| FY2024 | $59.1M | +106.1% |
| FY2023 | $28.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice